ClinicalTrials.govpublic full text
Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer
ovarian carcinoma, breast cancer, ovarian cancer, brca, triple negative, poly(adp ribose) polymerases, known brca or recurrent high grade serious/ undifferentiated tubo- ovarian carcinoma, known brca or triple negative breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 875157
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.